NYSE : CNC
Centene Corporation — Key statistics
Healthcare · Healthcare Plans · United States
Last price 68.45 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 33.89B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 33.89B |
| Enterprise Value | 28.73B |
Dates
| Measure | Value |
|---|
| Earnings Date | Oct 27, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 495.07M |
| Shares Outstanding | 495.07M |
| Shares Change (YoY) | +0.16% |
| Shares Change (QoQ) | -0.70% |
| Owned by Insiders (%) | 0.35% |
| Owned by Institutions (%) | 93.60% |
| Float | 464.74M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 23.19 |
| Forward PE | 12.93 |
| PS Ratio | 0.19 |
| Forward PS | 0.17 |
| PB Ratio | 1.53 |
| P/TBV Ratio | 4.62 |
| P/FCF Ratio | 8.59 |
| P/OCF Ratio | 7.17 |
| PEG Ratio | 0.34 |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 19.68 |
| EV / Sales | 0.16 |
| EV / EBITDA | 6.12 |
| EV / EBIT | 8.29 |
| EV / FCF | 7.29 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.16 |
| Quick Ratio | 1.12 |
| Debt / Equity | 0.70 |
| Debt / EBITDA | 3.24 |
| Debt / FCF | 3.94 |
| Interest Coverage | 5.46 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 6.74% |
| Return on Assets (ROA) | 2.68% |
| Return on Invested Capital (ROIC) | 6.88% |
| Return on Capital Employed (ROCE) | 8.61% |
| Weighted Average Cost of Capital (WACC) | 8.15% |
| Revenue Per Employee | $2.95M |
| Profits Per Employee | $23,895 |
| Employee Count | 61,100 |
| Asset Turnover | 2.24 |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | 459.00M |
| Effective Tax Rate | 23.91% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.13 |
| 52-Week Price Change | +83.32% |
| 50-Day Moving Average | 66.11 |
| 200-Day Moving Average | 55.35 |
| Relative Strength Index (RSI) | 53.35 |
| Average Volume (20 Days) | 4,743,818 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 10.93M |
| Short Previous Month | 14.13M |
| Short % of Shares Out | 2.21% |
| Short % of Float | 2.35% |
| Short Ratio (days to cover) | 2.30 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 180.41B |
| Gross Profit | 20.46B |
| Operating Income | 3.46B |
| Pretax Income | 1.92B |
| Net Income | 1.46B |
| EBITDA | 4.69B |
| EBIT | 3.46B |
| Earnings Per Share (EPS) | $2.95 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 23.59B |
| Total Debt | 15.54B |
| Net Cash | 5.16B |
| Net Cash Per Share | $10.42 |
| Equity (Book Value) | 22.31B |
| Book Value Per Share | 44.87 |
| Working Capital | 6.39B |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 4.72B |
| Capital Expenditures | -781.00M |
| Depreciation & Amortization | n/a |
| Net Borrowing | -2.06B |
| Free Cash Flow | 3.94B |
| FCF Per Share | $7.96 |
Margins
| Measure | Value |
|---|
| Gross Margin | 11.34% |
| Operating Margin | 1.92% |
| Pretax Margin | 1.06% |
| Profit Margin | 0.81% |
| EBITDA Margin | 2.60% |
| EBIT Margin | 1.92% |
| FCF Margin | 2.19% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -0.16% |
| Shareholder Yield | -0.16% |
| Earnings Yield | 4.31% |
| FCF Yield | 11.64% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $74.50 |
| Price Target Difference | 8.84% |
| Analyst Consensus | Buy |
| Analyst Count | 21 |
| Revenue Growth Forecast (3Y) | 4.54% |
| EPS Growth Forecast (3Y) | 47.18% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Feb 7, 2019 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | n/a |
| Piotroski F-Score | 7 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |